Studying a blood marker in rheumatoid arthritis and osteoarthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial measures levels of a protein called CCL-21 in the blood of people with rheumatoid arthritis, osteoarthritis, and healthy volunteers. The goal is to see if CCL-21 levels relate to disease activity and could help track inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 16 and 60 years old.
- You have been diagnosed with rheumatoid arthritis or osteoarthritis, or you are a healthy volunteer.
- You do not have diabetes, serious heart or blood disease, liver or kidney problems, or cancer.
- You do not have an active infection or other autoimmune diseases like lupus or psoriatic arthritis.
- If you have osteoarthritis, you have not had a steroid injection or taken oral steroids in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines joint tissue from people with different types of arthritis to understand the disease better. It may help researchers develop better treatments in the future.
This study looks at specific genetic differences and blood levels of immune proteins to see how they relate to rheumatoid arthritis risk and how active the disease is. It may help researchers understand who is more likely to have rheumatoid arthritis and when the condition is more active.
This study looks at a specific enzyme (15-hydroxyprostaglandin dehydrogenase) in people with osteoarthritis or ankylosing spondylitis. It may help researchers understand these conditions better and find new treatment targets.
This study looks at whether a new blood test (anti-PCOLCE) can help diagnose rheumatoid arthritis, especially in people who test negative for standard markers.
This study looks at levels of certain immune system proteins (IL-6, IL-12, IL-15, and IL-23) in the blood of people with rheumatoid arthritis. It aims to understand how these proteins relate to the disease and may help guide future treatments for better outcomes.
This study measures two proteins in your blood (COMP and MMP-3) to see if they can help doctors understand how severe knee osteoarthritis is. Researchers compare people with knee arthritis to people without it to learn if these blood tests might help diagnose or track the condition.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.